Comparison of serum and urinary C-terminal telopeptide of type I collagen in aging, menopause and osteoporosis

Clinica Chimica Acta

Volumn 316, Issue 1-2, 2002, Pages 109-115

  Kawana, K ^a   Takahashi, M ^a   Hoshino, H ^a   Kushida, K ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bone marker; Bone resorption; Hip fracture; Menopause; Vertebral fracture

Indexed keywords

COLLAGEN TYPE 1; PEPTIDE DERIVATIVE;

ADULT; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIP FRACTURE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; VERTEBRA FRACTURE;

ADULT; AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; BONE RESORPTION; CASE-CONTROL STUDIES; COLLAGEN; COLLAGEN TYPE I; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIP FRACTURES; HUMANS; MENOPAUSE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PEPTIDES; RADIOIMMUNOASSAY; REAGENT KITS, DIAGNOSTIC; SPINAL FRACTURES;

EID: 0036135176     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00742-2     Document Type: Article

References (22)

1. Immunoassay for quantifying type I collagen degradation products in urine evaluated
2. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion
3. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease
4. Application of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): Follow-up on hormone replacement therapy and osteoporosis risk assessment
5. New biochemical markers of bone resorption derived from collagen breakdown in the study of postmenopausal osteoporosis
6. Characterization of urinary degradation products derived from type I collagen
7. Coated-tube radioimmunoassay for C-telopeptides of type I collagen to assess bone resorption
8. Decreased β-isomerization of the C-terminal telopeptide of type I collagen α1 chain in Paget's disease of bone
9. Measurement of bone degradation products in serum using antibodies reactive with an isomerized from of an 8 amino acid sequence of the C-telopeptide of type I collagen
10. Urinary excretion of type I collagen degradation products in healthy women and osteoporotic patients with vertebral and hip fractures
11. The measurements of urinary nonisomerized form of type I collagen degradation products (a-CTx) on aging, menopause, and osteoporosis with fractures
12. The relationships between the degree of β-isomerization of type I collagen degradation products in the urine and aging, menopause and osteoporosis with fractures
13. Vertebral fracture assessment using a semiquantitative technique
14. Effect of fracture to biochemical markers and vitamin K in acute phase of patients with hip fracture
15. High bone turnover is associated with low bone mass in both pre- and postmenopausal women
16. New biochemical markers of bone resorption in the study of postmenopausal osteoporosis
17. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis
18. Changes in urinary excretion of type I collagen cross-linked C-telopeptide and N-telopeptide in perimenopausal women
19. Bone metabolism and bone status in osteoporotic patients
20. Impairment of bone turnover in elderly women with hip fracture
21. Evaluation of bone turnover in postmenopause, vertebral fracture and hip fracture using biochemical markers for bone formation and resorption
22. The effect of menopause on biochemical markers and ultrasound densitometry